81 FR 46696 - Notice of Kidney Interagency Coordinating Committee Meeting
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health Federal Register Volume 81, Issue 137 (July 18, 2016)
National Institutes of Health
Federal Register Volume 81, Issue 137 (July 18, 2016)
| Page Range | 46696-46697 | |
| FR Document | 2016-16907 |
[Federal Register Volume 81, Number 137 (Monday, July 18, 2016)] [Notices] [Pages 46696-46697] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2016-16907] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Notice of Kidney Interagency Coordinating Committee Meeting SUMMARY: The Kidney Interagency Coordinating Committee (KICC) will hold a meeting on September 19, 2016, on ``CRIC and CKiD: Using longitudinal CKD cohort study findings to plan population health interventions.'' The meeting is open to the public. DATES: The meeting will be held on September 19, 2016, 9 a.m. to 12 p.m. Individuals wanting to present oral comments must notify the contact person at least 10 days before the meeting date. ADDRESSES: The meeting will be held in the Natcher Conference Center on the NIH Campus at 9000 Rockville Pike, Bethesda, MD 20894. FOR FURTHER INFORMATION CONTACT: For further information concerning this meeting, contact Dr. Andrew S. Narva, Executive Secretary of the Kidney Interagency Coordinating Committee, National Institute of Diabetes and Digestive and Kidney Diseases, 6707 Democracy Blvd., MSC 5458, Bethesda, MD 20892-5458, telephone: 301-594-8864; FAX: 301-480- 3510; email: [email protected]. SUPPLEMENTARY INFORMATION: The KICC, chaired by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), comprises members of the Department of Health and Human [[Page 46697]] Services and other federal agencies that support kidney-related activities, facilitates cooperation, communication, and collaboration on kidney disease among government entities. KICC meetings, held twice a year, provide an opportunity for Committee members to learn about and discuss current and future kidney programs in KICC member organizations and to identify opportunities for collaboration. The September 19, 2016 KICC meeting will focus on ``CRIC and CKiD: Using longitudinal CKD cohort study findings to plan population health interventions.'' Any member of the public interested in presenting oral comments to the Committee should notify the contact person listed on this notice at least 10 days in advance of the meeting. Interested individuals and representatives or organizations should submit a letter of intent, a brief description of the organization represented, and a written copy of their oral presentation in advance of the meeting. Only one representative of an organization will be allowed to present; oral comments and presentations will be limited to a maximum of 5 minutes. Printed and electronic copies are requested for the record. In addition, any interested person may file written comments with the Committee by forwarding their statement to the contact person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Because of time constraints for the meeting, oral comments will be allowed on a first-come, first-serve basis. Members of the public who would like to receive email notification about future KICC meetings should send a request to [email protected]. Dated: July 6, 2016. Camille M. Hoover, Executive Officer, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health. [FR Doc. 2016-16907 Filed 7-15-16; 8:45 am] BILLING CODE 4140-01-P
![46696 Federal Register / Vol. 81, No. 137 / Monday, July 18, 2016 / Notices
provisions set forth in sections FOR FURTHER INFORMATION CONTACT: Dr. submitted or for its use of that
552b(c)(4) and 552b(c)(6), title 5 U.S.C., Warren Casey, Director, NICEATM; information.
as amended. The grant applications and email: warren.casey@nih.gov; telephone: Background Information on
the discussions could disclose (919) 316–4729. NICEATM: NICEATM conducts data
confidential trade secrets or commercial SUPPLEMENTARY INFORMATION: analyses, workshops, independent
property such as patentable material, Background: Acute systemic toxicity validation studies, and other activities
and personal information concerning tests are conducted to determine the to assess new, revised, and alternative
individuals associated with the grant potential for a single or short-term dose test methods and strategies. NICEATM
applications, the disclosure of which of a substance to cause illness or death also provides support for the
would constitute a clearly unwarranted when inhaled (inhalation toxicity Interagency Coordinating Committee on
invasion of personal privacy. testing), swallowed (oral toxicity the Validation of Alternative Methods
Name of Committee: National Eye Institute testing), or absorbed through the skin (ICCVAM). The ICCVAM Authorization
Special Emphasis Panel; NEI Translational (dermal toxicity testing). These tests are Act of 2000 (42 U.S.C. 285l–3) provides
Research (R24) and Patient-Oriented required by multiple regulatory agencies authority for ICCVAM and NICEATM in
Mentored Training (K23) Grant Applications. and can use large numbers of animals. the development of alternative test
Date: August 4, 2016. NICEATM, which fosters the evaluation methods. Information about NICEATM
Time: 8:00 a.m. to 5:00 p.m. and ICCVAM is found at http://
Agenda: To review and evaluate grant
and promotion of alternative test
methods for regulatory use, supports ntp.niehs.nih.gov/go/niceatm and
applications.
efforts to develop, validate, and http://ntp.niehs.nih.gov/go/iccvam.
Place: Embassy Suites at the Chevy Chase
Pavilion, Tenleytown Ballroom II, 4300 implement alternative approaches for Dated: July 12, 2016.
Military Road NW., Washington, DC 20015. acute systemic toxicity testing that John R. Bucher,
Contact Person: Anne E. Schaffner, Ph.D., replace, reduce, or refine use of animals Associate Director, National Toxicology
Chief, Scientific Review Branch Division of in testing. Program.
Extramural Research, National Eye Institute, Request for Information: NICEATM
5635 Fishers Lane, Suite 1300, MSC 9300, [FR Doc. 2016–16840 Filed 7–15–16; 8:45 am]
Bethesda, MD 20892–9300, (301) 451–2020,
requests data and information on BILLING CODE 4140–01–P
aes@nei.nih.gov. approaches and/or technologies
(Catalogue of Federal Domestic Assistance
currently used to identify substances
Program Nos. 93.867, Vision Research, with the potential to cause acute DEPARTMENT OF HEALTH AND
National Institutes of Health, HHS) systemic toxicity. Respondents should HUMAN SERVICES
provide information on any activities
Dated: July 12, 2016.
relevant to the development or National Institutes of Health
Natasha M. Copeland, validation of alternatives to in vivo tests
Program Analyst, Office of Federal Advisory currently required by regulatory Notice of Kidney Interagency
Committee Policy. agencies that assess acute oral, dermal, Coordinating Committee Meeting
[FR Doc. 2016–16833 Filed 7–15–16; 8:45 am] or inhalation toxicity. Of specific SUMMARY: The Kidney Interagency
BILLING CODE 4140–01–P interest are chemical-specific data from Coordinating Committee (KICC) will
non-animal tests for acute systemic hold a meeting on September 19, 2016,
toxicity hazard, as well as available data on ‘‘CRIC and CKiD: Using longitudinal
DEPARTMENT OF HEALTH AND on the same chemicals from in vivo
HUMAN SERVICES CKD cohort study findings to plan
acute systemic toxicity tests, such as population health interventions.’’ The
National Institutes of Health ethical human or animal studies or meeting is open to the public.
accidental human exposures.
DATES: The meeting will be held on
Request for Data and Information on Respondents to this request for
September 19, 2016, 9 a.m. to 12 p.m.
Technologies Used To Identify information should include their name,
Individuals wanting to present oral
Substances With the Potential To affiliation (if applicable), mailing
comments must notify the contact
Cause Acute Systemic Toxicity address, telephone, email, and
person at least 10 days before the
sponsoring organization (if any) with
SUMMARY: The National Toxicology meeting date.
their communications. The deadline for
Program (NTP) Interagency Center for receipt of the requested information is ADDRESSES: The meeting will be held in
the Evaluation of Alternative September 1, 2016. Responses to this the Natcher Conference Center on the
Toxicological Methods (NICEATM) notice will be posted at http:// NIH Campus at 9000 Rockville Pike,
requests data and information on ntp.niehs.nih.gov/go/iv-data. Persons Bethesda, MD 20894.
approaches and/or technologies submitting responses will be identified FOR FURTHER INFORMATION CONTACT: For
currently used to identify substances on the Web page by name and affiliation further information concerning this
with the potential to cause acute or sponsoring organization, if meeting, contact Dr. Andrew S. Narva,
systemic toxicity when swallowed, applicable. Executive Secretary of the Kidney
inhaled, or absorbed through the skin. Responses to this request are Interagency Coordinating Committee,
Submitted information will be used to voluntary. No proprietary, classified, National Institute of Diabetes and
assess the state of the science and confidential, or sensitive information Digestive and Kidney Diseases, 6707
determine technical needs for non- should be included in responses. This Democracy Blvd., MSC 5458, Bethesda,
asabaliauskas on DSK3SPTVN1PROD with NOTICES
animal test methods used to evaluate request for information is for planning MD 20892–5458, telephone: 301–594–
the potential of chemicals to induce purposes only and is not a solicitation 8864; FAX: 301–480–3510; email:
acute systemic toxicity. for applications or an obligation on the healthinfo@niddk.nih.gov.
DATES: Receipt of information: Deadline part of the U.S. Government to provide SUPPLEMENTARY INFORMATION: The KICC,
is September 1, 2016. support for any ideas identified in chaired by the National Institute of
ADDRESSES: Data and information response to the request. Please note that Diabetes and Digestive and Kidney
should be submitted electronically to the U.S. Government will not pay for Diseases (NIDDK), comprises members
niceatm@niehs.nih.gov. the preparation of any information of the Department of Health and Human
VerDate Sep<11>2014 17:52 Jul 15, 2016 Jkt 238001 PO 00000 Frm 00057 Fmt 4703 Sfmt 4703 E:\FR\FM\18JYN1.SGM 18JYN1](https://thefederalregister.org/doc/81_FR_46833/page/1.svg)
![Federal Register / Vol. 81, No. 137 / Monday, July 18, 2016 / Notices 46697
Services and other federal agencies that amended (5 U.S.C. App.), notice is be closed to the public from 9:00 a.m.
support kidney-related activities, hereby given of the following meeting. to 12:00 p.m. as determined by the
facilitates cooperation, communication, The meeting will be closed to the Principle Deputy Administrator, in
and collaboration on kidney disease public in accordance with the accordance with title 5 U.S.C. 552b(c)(4)
among government entities. KICC provisions set forth in sections and (6). The remainder of this meeting
meetings, held twice a year, provide an 552b(c)(4) and 552b(c)(6), title 5 U.S.C., will be open to the public from 12:00
opportunity for Committee members to as amended. The contract proposals and p.m. to 5:00 p.m. to include
learn about and discuss current and the discussions could disclose presentations on Improving Inpatient
future kidney programs in KICC member confidential trade secrets or commercial
Care and Family Caregiver Challenges
organizations and to identify property such as patentable material,
and Solutions.
opportunities for collaboration. The and personal information concerning
September 19, 2016 KICC meeting will individuals associated with the contract The meeting will be held at SAMHSA,
focus on ‘‘CRIC and CKiD: Using proposals, the disclosure of which 5600 Fishers Lane, 5th Floor,
longitudinal CKD cohort study findings would constitute a clearly unwarranted Conference Room A03, Rockville, MD
to plan population health invasion of personal privacy. 20857. Attendance by the public will be
interventions.’’ Name of Committee: National Institute of limited to space available. Interested
Any member of the public interested Allergy and Infectious Diseases Special persons may present data, information,
in presenting oral comments to the Emphasis Panel; NIAID Peer Review Meeting. or views, orally or in writing, on issues
Date: August 4, 2016. pending before the committee. Written
Committee should notify the contact Time: 11:00 a.m. to 4:00 p.m.
person listed on this notice at least 10 submissions should be forwarded to the
Agenda: To review and evaluate contract
days in advance of the meeting. proposals. contact person (below) on or before
Interested individuals and Place: National Institutes of Health, 5601 August 10, 2016. Oral presentations
representatives or organizations should Fishers Lane, Rockville, MD 20892 from the public will be scheduled at the
submit a letter of intent, a brief (Telephone Conference Call). conclusion of the meeting.
description of the organization Contact Person: Robert C. Unfer, Ph.D.,
Scientific Review Officer, Scientific Review The meeting can be accessed via
represented, and a written copy of their Program, DEA/NIAID/NIH/DHHS, 5601 telephone. To obtain the conference
oral presentation in advance of the Fishers Lane, Room 3F40, MSC 9823, call-in number and access code, submit
meeting. Only one representative of an Rockville, MD 20892–9823, 240–669–5035, written or brief oral comments, or
organization will be allowed to present; unferrc@nih.gov. request special accommodations for
oral comments and presentations will be (Catalogue of Federal Domestic Assistance persons with disabilities, please register
limited to a maximum of 5 minutes. Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856, at the SAMHSA’s Advisory Committees
Printed and electronic copies are
Microbiology and Infectious Diseases Web site at http://nac.samhsa.gov/
requested for the record. In addition,
any interested person may file written Research, National Institutes of Health, HHS) Registration/meetingsRegistration.aspx,
comments with the Committee by Dated: July 12, 2016. or contact Pamela Foote (see contact
forwarding their statement to the Natasha M. Copeland, information below).
contact person listed on this notice. The Program Analyst, Office of Federal Advisory Committee Name: Substance Abuse
statement should include the name, Committee Policy. and Mental Health Services
address, telephone number and when [FR Doc. 2016–16834 Filed 7–15–16; 8:45 am] Administration Center for Mental
applicable, the business or professional BILLING CODE 4140–01–P Health Services National Advisory
affiliation of the interested person. Council.
Because of time constraints for the
Dates/Time/Type: Wednesday,
meeting, oral comments will be allowed DEPARTMENT OF HEALTH AND
August 24, 2016, 9:00 a.m. to 12:00 p.m.
on a first-come, first-serve basis. HUMAN SERVICES
EDT: CLOSED; Wednesday, August 24,
Members of the public who would 2016, 12:00 p.m. to 5:00 p.m. EDT:
Substance Abuse and Mental Health
like to receive email notification about OPEN.
Services Administration
future KICC meetings should send a
request to healthinfo@niddk.nih.gov. Place: SAMHSA, 5600 Fishers Lane,
Center for Mental Health Services;
5th Floor, Conference Room A03,
Dated: July 6, 2016. Notice of Meeting
Rockville, Maryland 20857.
Camille M. Hoover,
Pursuant to Public Law 92–463, Contact: Pamela Foote, Acting
Executive Officer, National Institute of notice is hereby given that the
Diabetes and Digestive and Kidney Diseases, Designated Federal Official, SAMHSA
Substance Abuse and Mental Health CMHS National Advisory Council, 5600
National Institutes of Health.
Services Administration (SAMHSA), Fishers Lane, Room 14E53C, Rockville,
[FR Doc. 2016–16907 Filed 7–15–16; 8:45 am]
Center for Mental Health Services
BILLING CODE 4140–01–P Maryland 20857, Telephone: (240) 276–
(CMHS) National Advisory Council
1279, Fax: (301) 480–8491, Email:
(NAC) will meet on August 24, 2016,
pamela.foote@samhsa.hhs.gov.
from 9:00 a.m. to 5:00 p.m. E.D.T. The
DEPARTMENT OF HEALTH AND
NAC will convene in both open and Summer King,
HUMAN SERVICES
closed sessions.
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Statistician, Substance Abuse and Mental
National Institutes of Health The closed portion of the meeting will Health Services Administration.
include discussion and evaluation of [FR Doc. 2016–16829 Filed 7–15–16; 8:45 am]
National Institute of Allergy and grant review applications by SAMHSA’s
BILLING CODE 4162–20–P
Infectious Diseases; Notice of Closed Initial Review Groups, and involve an
Meeting examination of confidential financial
and business information as well as
Pursuant to section 10(d) of the personal information concerning the
Federal Advisory Committee Act, as applicants. Therefore, the meeting will
VerDate Sep<11>2014 17:52 Jul 15, 2016 Jkt 238001 PO 00000 Frm 00058 Fmt 4703 Sfmt 9990 E:\FR\FM\18JYN1.SGM 18JYN1](https://thefederalregister.org/doc/81_FR_46833/page/2.svg)
Document Created: 2016-07-16 02:28:37
Document Modified: 2016-07-16 02:28:37
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Dates | The meeting will be held on September 19, 2016, 9 a.m. to 12 p.m. Individuals wanting to present oral comments must notify the contact person at least 10 days before the meeting date. | |
| Contact | For further information concerning this meeting, contact Dr. Andrew S. Narva, Executive Secretary of the Kidney Interagency Coordinating Committee, National Institute of Diabetes and Digestive and Kidney Diseases, 6707 Democracy Blvd., MSC 5458, Bethesda, MD 20892-5458, telephone: 301-594-8864; FAX: 301-480- 3510; email: [email protected] | |
| FR Citation | 81 FR 46696 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR